DOSING AND ADMINISTRATION: RECONSTITUTING REBLOZYL

REBLOZYL should be reconstituted and administered by a healthcare professional1

  • REBLOZYL is administered subcutaneously and is available in 2 vial sizes (25 mg and 75 mg)
  • Reconstitute REBLOZYL with Sterile Water for Injection, USP only

Reconstitution volumes

 Vial size Amount of Sterile Water for
Injection, USP required for
reconstitution 
Final concentration Deliverable volume
25 mg 0.68 mL 25 mg/0.5 mL 0.5 mL
75 mg 1.6 mL 75 mg/1.5 mL 
(50 mg/mL)
1.5 mL

Important considerations for REBLOZYL reconstitution

  • Reconstitute the number of REBLOZYL vials required to achieve the appropriate dose based on the patient’s weight
  • Use a syringe with suitable graduations for reconstitution to ensure accurate dosage

Instructions for reconstituting REBLOZYL1

Adhere to the following steps to properly reconstitute REBLOZYL for SC injection

Syringe

Step 1: Add Sterile Water for Injection, USP

Reconstitute with Sterile Water for Injection, USP using volumes described in the Reconstitution Volumes table above with the stream directed onto the lyophilized powder. Allow to stand for 1 minute.

Syringe disposal

Step 2: Discard the needle and syringe used for reconstitution

The needle and syringe used for reconstitution should not be used for SC injections.

Vial

Step 3: Mix and wait

Gently swirl the vial in a circular motion for 30 seconds. Stop swirling and let the vial sit in an upright position for 30 seconds.

Inspect vial

Step 4: Inspect the solution

Inspect the solution for undissolved particles. If undissolved powder is observed, repeat step 3 until the powder is completely dissolved.

Mix vial

Step 5: Mix and wait

Invert the vial and gently swirl in an inverted position for 30 seconds. Bring the vial back to the upright position, and let it sit for 30 seconds.

Observe vial

Step 6: Ensure reconstitution

Repeat step 5 seven more times to ensure complete reconstitution of material on the sides of the vial.

REBLOZYL vial

Step 7: Inspect

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. REBLOZYL is a colorless to slightly yellow, clear to slightly opalescent solution, which is free of foreign particulate matter. Do not use if undissolved product or foreign particulate matter is observed.

Learn about storing REBLOZYL

Reference: 1. REBLOZYL [US Prescribing Information]. Summit, NJ: Celgene Corporation; 2024.



REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.
Access Support® is a trademark of Bristol-Myers Squibb Company.
REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2024 Bristol-Myers Squibb Company.   
2007-US-2400451   12/2024